Aglatimagene besadenovec + valacyclovir

Drug identity checked against registry records

Also recorded as AdV-tk; CAN-2409

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerNCT01436968CADLPhase 3Active not recruiting2024-08Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.